STRATFORD, Conn., June 12 /PRNewswire/ -- Vertebron, Inc., a U.S.-based spinal implant manufacturer, held its annual Shareholder Meeting Monday, June 9, 2008 in which Paul Sendro, the new President and CEO presented a favorable picture of the business as his new management team gains momentum.
Paul Sendro, with more than 18 years experience in Orthopedics, assumed his new position in October of 2007 and has since been assembling his team of highly experienced professionals to lead the company into a new era of growth and innovation.
With the new leadership team, including Alex Hart, Chief Financial Officer; John Moccio, Controller; Diane Venitelli, Vice President, Marketing; Brian Dukate, Vice President, Sales; Derek Holland, Vice President, Professional Relations; Mike Kolisek, Vice President, Business Development; Dina Weissman, Vice President, Legal, and Dave Lamb, Director of Operations; as well as the talent of Bruce Khalili, Chief Technology Officer, the company is reaching milestones not yet seen in the business.
As part of its plan to bring talented members to the Vertebron(R) team, the shareholders approved the appointment of the newest member of the Board of Directors, Chad Hellmann. Chad is the Chief Financial Officer and a Partner at Cat Trail Capital, a boutique merchant bank that concentrates on small to middle-market companies in the media, technology and biotech sectors. The firm specializes in assisting companies better monetize their assets through strategic capital raises, product licensing, and/or developing achievable exit strategies. "I look forward to working with Bruce, Paul and the rest of the Vertebron team in identifying and capitalizing on the numerous strategic alternatives available to a company of this caliber."
Despite unfavorable market conditions, Vertebron continues to double sales from the previous year. A new fortified sales team has enabled the company to grow its distribution network and increase its customer base fourfold. New operational structure has increased sales efficiency and improved market acceptance. A recently featured article in the popular investment magazine MicroCap identifying Vertebron as a leader in Intellectual Property and a company to watch adds credence to the potential and excitement of this growing business.
"Vertebron will continue to drive a comprehensive and cohesive marketing strategy, launch new, innovative products, expand distribution channels and tighten up processes for better customer relations," says Paul. "I am confident that the new team will be successful in increasing the company value and thereby increasing shareholder wealth."
Vertebron is a privately held medical device company that has developed next-generation spinal implants, including artificial discs (motion preservation), cervical plates, pedicle screws and interbody fusion systems that integrate spinal, orthopedic and total joint technologies. Vertebron's comprehensive product portfolio offers simplified surgical techniques with enhanced intra-operative flexibility and innovative instrumentation to spinal surgeons worldwide. For more information, please visit http://www.vertebron.com.
While this press release contains certain forward-looking statements, actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, risks and uncertainties detailed from time to time in Vertebron's Business Plan and other documents and as a result of other known and unknown risks and factors.
For more information, please contact: Diane Venitelli, Vice President, Marketing at 203 380 9340 or email@example.com.
Vision: envisioning innovative, simplified solutions through experience and ingenuity.
Versatility: creating comprehensive, adaptable solutions to address the continuum of spinal care.
Value: delivering efficient, effective solutions to ensure reliable performance with premiere service.
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.
CONTACT: Diane Venitelli, Vice President, Marketing of Vertebron, Inc.,
Web site: http://www.vertebron.com/